Abris, a group of PE funds, has acquired a leading European mushroom substrate manufacturer, Mykogen, in 2012 when Abris CEE Mid-Market Fund II subsidiary had acquired majority stake in the company.
Haitong Bank, the financial advisor, supported Abris in finding an investor for the company, which would be interested in further development of its business and continued success. Abris decided on selling Mykogen to Greenyard, a global market leader in fresh and prepared fruits and vegetables, flowers and plants and growing media. On 14th June 2017 a preliminary contract for the sale of Mykogen has been signed. The transaction is conditional upon the receipt of all necessary regulatory and third party approvals, and other customary conditions. Closing is expected to occur during the second half of 2017.